Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Arerugi = [Allergy]|May 24, 2023
[CLINICAL EFFICASY OF HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY WITH MITICURE® TABLETS IN 115 PAITENTS FOR 3 YEARS]Atsushi Yuta, Yukiko Ogawa, Hideaki Kozaki, et al.
Arerugi = [Allergy]|December 13, 2023
[CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH CEDAR POLLEN IN A YEAR OF MASSIVE CEDAR POLLEN DISPERSAL AND ITS EFFECT ON JAPANESE CYPRESS POLLINOSIS]Atsushi Yuta, Yukiko Ogawa, Hideaki Kozaki, et al.
Arerugi = [Allergy]|June 11, 2025
[CHANGES IN CEDAR POLLEN SPECIFIC IGE ANTIBODIES TITER BY CEDAR SUBLINGUAL IMMUNOTHERAPY ARE SYNCHRONIZED WITH OTHER POLLEN ANTIGENS, BUT NOT WITH PERENNIAL ANTIGENS]Atsushi Yuta, Yukiko Ogawa, Keigo Nakamura, et al.
Arerugi = [Allergy]|November 13, 2022
[ENHANCED CLINICAL EFFECTS OF CEDARCURE® TABLETS OF SUBLINGUAL IMMUNOTHERAPY OVER THE YEARS OF TREATMENT AND THE IMPACT OF OUTCOME BY COMBINED USE OF MITE SUBLINGUAL IMMUNOTHERAPY (DUAL SLIT) FOR JAPANESE CEDAR POLLINOSIS]Atsushi Yuta, Yukiko Ogawa, Takuya Murao, et al.
Arerugi = [Allergy]|May 20, 2021
[COMPARISON OF CLINICAL EFFICACY AND SAFETY BETWEEN CHILDREN AND ADULTS BEFORE AND 1 YEAR AFTER MITE SUBLINGUAL IMMUNOTHERAPY FOR PERENNIAL ALLERGIC RHINITIS]Atsushi Yuta, Yukiko Ogawa, Yusuke Suzuki, et al.
Arerugi = [Allergy]|November 16, 2020
[EFFICACY AND SAFETY OF PEDIATRIC SUBLINGUAL IMMMUNOTHERAPY WITH CEDARCURE® IN CLINICAL PRACTICE FOR JAPANESE CEDAR POLLINOSIS IN THE FIRST FOLLOW-UP SEASON]Atsushi Yuta, Yukiko Ogawa, Yusuke Suzuki, et al.
Arerugi = [Allergy]|September 20, 2019
[CLINICAL EFFICACY OF 69 PATIENTS WITH JAPANESE CEDAR POLLINOSIS TREATED BY SUBLINGUAL IMMUNOTHERAPY WITH CEDARCURE® IN THE FIRST FOLLOW-UP YEAR]Atsushi Yuta, Yukiko Ogawa, Yusuke Suzuki, et al.
Arerugi = [Allergy]|April 12, 2026
[POST-TREATMENT SURVEY OF THE MAINTENANCE OF EFFECTS FOR CEDAR SUBLINGUAL IMMUNOTHERAPY]Atsushi Yuta, Yukiko Ogawa, Hideaki Kozaki, et al.
Nihon Jibiinkoka Gakkai Kaiho|July 24, 2018
Enhanced Clinical Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis in the Second Year of TreatmentAtsushi Yuta, Yukiko Ogawa, Yusuke Suzuki, et al.
Nihon Jibiinkoka Gakkai Kaiho|July 24, 2018
Adherence and Clinical Outcome of Sublingual Immunotherapy for Japanese Cedar PollinosisAtsushi Yuta, Yukiko Ogawa, Yusuke Suzuki, et al.
Pageof 2